EA200400885A1 - Диспергируемая во рту фармацевтическая композиция пирибедила - Google Patents

Диспергируемая во рту фармацевтическая композиция пирибедила

Info

Publication number
EA200400885A1
EA200400885A1 EA200400885A EA200400885A EA200400885A1 EA 200400885 A1 EA200400885 A1 EA 200400885A1 EA 200400885 A EA200400885 A EA 200400885A EA 200400885 A EA200400885 A EA 200400885A EA 200400885 A1 EA200400885 A1 EA 200400885A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyribeed
dispertable
mouth
pharmaceutical composition
piribedil
Prior art date
Application number
EA200400885A
Other languages
English (en)
Other versions
EA007286B1 (ru
Inventor
Патрик Вутрих
Эрве Роллан
Марк Жюльен
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200400885A1 publication Critical patent/EA200400885A1/ru
Publication of EA007286B1 publication Critical patent/EA007286B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Abstract

Изобретение касается твердой диспергируемой в ротовой полости композиции пирибедила, отличающейся тем, что она включает пирибедил или его фармацевтически приемлемую соль и гранулы, состоящие из совместно высушенных лактозы и крахмала.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400885A 2002-01-21 2003-01-21 Диспергируемая во рту фармацевтическая композиция пирибедила EA007286B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil
PCT/FR2003/000179 WO2003061661A1 (fr) 2002-01-21 2003-01-21 Composition pharmaceutic orodispersible de piribedil

Publications (2)

Publication Number Publication Date
EA200400885A1 true EA200400885A1 (ru) 2004-12-30
EA007286B1 EA007286B1 (ru) 2006-08-25

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400885A EA007286B1 (ru) 2002-01-21 2003-01-21 Диспергируемая во рту фармацевтическая композиция пирибедила

Country Status (27)

Country Link
US (1) US20050085485A1 (ru)
EP (1) EP1467737B1 (ru)
JP (1) JP4500051B2 (ru)
KR (1) KR100588223B1 (ru)
CN (1) CN100352440C (ru)
AR (1) AR038194A1 (ru)
AT (1) ATE327758T1 (ru)
AU (1) AU2003214326B2 (ru)
BR (1) BR0306869A (ru)
CA (1) CA2473152C (ru)
CY (1) CY1105414T1 (ru)
DE (1) DE60305642T2 (ru)
DK (1) DK1467737T3 (ru)
EA (1) EA007286B1 (ru)
ES (1) ES2263959T3 (ru)
FR (1) FR2834894B1 (ru)
GE (1) GEP20063819B (ru)
HK (1) HK1081110A1 (ru)
MA (1) MA27098A1 (ru)
MX (1) MXPA04007035A (ru)
NO (1) NO20043474L (ru)
NZ (1) NZ533820A (ru)
PL (1) PL204939B1 (ru)
PT (1) PT1467737E (ru)
UA (1) UA78277C2 (ru)
WO (1) WO2003061661A1 (ru)
ZA (1) ZA200405008B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (ru) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1007083A1 (en) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
WO2002007957A2 (en) * 2000-07-24 2002-01-31 Boehringer Ingelheim Pharmaceuticals, Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose
UA80393C2 (ru) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
CA2473152A1 (fr) 2003-07-31
PT1467737E (pt) 2006-08-31
CA2473152C (fr) 2010-08-31
CY1105414T1 (el) 2010-04-28
CN100352440C (zh) 2007-12-05
AU2003214326B2 (en) 2007-08-02
NO20043474L (no) 2004-08-20
MA27098A1 (fr) 2004-12-20
KR20040075098A (ko) 2004-08-26
JP2005529068A (ja) 2005-09-29
UA78277C2 (en) 2007-03-15
ATE327758T1 (de) 2006-06-15
EP1467737B1 (fr) 2006-05-31
NZ533820A (en) 2005-08-26
FR2834894A1 (fr) 2003-07-25
US20050085485A1 (en) 2005-04-21
EA007286B1 (ru) 2006-08-25
DK1467737T3 (da) 2006-09-18
AR038194A1 (es) 2005-01-05
PL370168A1 (en) 2005-05-16
GEP20063819B (en) 2006-05-10
WO2003061661A1 (fr) 2003-07-31
DE60305642D1 (de) 2006-07-06
PL204939B1 (pl) 2010-02-26
MXPA04007035A (es) 2004-10-11
FR2834894B1 (fr) 2004-02-27
BR0306869A (pt) 2004-11-03
ZA200405008B (en) 2005-08-31
KR100588223B1 (ko) 2006-06-12
JP4500051B2 (ja) 2010-07-14
ES2263959T3 (es) 2006-12-16
EP1467737A1 (fr) 2004-10-20
HK1081110A1 (en) 2006-05-12
CN1688313A (zh) 2005-10-26
DE60305642T2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
EA200400928A1 (ru) Диспергируемая во рту фармацевтическая композиция агомелатина
CY1105655T1 (el) Φαρμακευτικη οροδιασπειρομενη συνθεση περινδοπριλης
GEP20074047B (en) Pramipexole once-daily dosage form
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
WO2003047520A3 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
MY148466A (en) Granule formulation
CY1108854T1 (el) Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
EA200400357A1 (ru) Дезинтегрирующиеся в ротовой полости композиции валдекоксиба
EA200401227A1 (ru) Система доставки лекарства с контролируемым высвобождением, включающая правастатин
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
NO20060803L (no) Orodispersibel farmasoytisk sammensetning av en antitrombotisk forbindelse
EA200400885A1 (ru) Диспергируемая во рту фармацевтическая композиция пирибедила
MX2021010338A (es) Composicion farmaceutica que contiene acetominofeno e ibuprofeno.
ME00452B (me) Mikrokapsule za odloženo i kontrolisano oslobadjanje perindoprila
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
EE200400069A (et) Tsitalopraami kasutamine ravimkoostiste valmistamiseks kõrgenenud vererõhu raviks
WO2001060344A3 (en) Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections
EP1702921A4 (en) BETA-LACTAMASE-RESISTANT ESTER-CEPHALOSPORINE COMPOUNDS AND SALTS THEREOF
AU2003214326A1 (en) Orally dispersible pharmaceutical piribedil composition
IT1317858B1 (it) Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
WO2005115092A3 (en) Micronized oral pharmaceutical composition
HUP0401446A3 (en) Heterocondensated indole and heteroindole derivatives, the production and use thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU